| Year |
Citation |
Score |
| 2019 |
Cavallone LF, Montana MC, Frey K, Kallogjeri D, Wages JM, Rodebaugh T, Doshi T, Kharasch ED, Gereau RW. The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects. Pain. PMID 31568235 DOI: 10.1097/J.Pain.0000000000001695 |
0.616 |
|
| 2019 |
Zhang H, Gutruf P, Meacham K, Montana MC, Zhao X, Chiarelli AM, Vázquez-Guardado A, Norris A, Lu L, Guo Q, Xu C, Wu Y, Zhao H, Ning X, Bai W, et al. Wireless, battery-free optoelectronic systems as subdermal implants for local tissue oximetry. Science Advances. 5: eaaw0873. PMID 30873435 DOI: 10.1126/Sciadv.Aaw0873 |
0.707 |
|
| 2018 |
Cao LQ, Montana MC, Germann AL, Shin DJ, Chakrabarti S, Mennerick S, Yuede CM, Wozniak DF, Evers AS, Akk G. Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam. Scientific Reports. 8: 10341. PMID 29985445 DOI: 10.1038/S41598-018-28754-7 |
0.301 |
|
| 2015 |
Park SI, Brenner DS, Shin G, Morgan CD, Copits BA, Chung HU, Pullen MY, Noh KN, Davidson S, Oh SJ, Yoon J, Jang KI, Samineni VK, Norman M, Grajales-Reyes JG, ... ... Montana MC, et al. Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics. Nature Biotechnology. PMID 26551059 DOI: 10.1038/Nbt.3415 |
0.539 |
|
| 2013 |
Cavallone LF, Frey K, Montana MC, Joyal J, Regina KJ, Petersen KL, Gereau RW. Reproducibility of the heat/capsaicin skin sensitization model in healthy volunteers. Journal of Pain Research. 6: 771-84. PMID 24232380 DOI: 10.2147/Jpr.S53437 |
0.558 |
|
| 2013 |
Cavallone L, Montana M, Frey K, Joyal J, Gereau R. Reproducibility of the heat/capsaicin sensitization model: a double blind, crossover, randomized, controlled study in healthy volunteers The Journal of Pain. 14: S50. DOI: 10.1016/J.Jpain.2013.01.537 |
0.515 |
|
| 2011 |
Montana MC, Conrardy BA, Cavallone LF, Kolber BJ, Rao LK, Greco SC, Gereau RW. Metabotropic glutamate receptor 5 antagonism with fenobam: examination of analgesic tolerance and side effect profile in mice. Anesthesiology. 115: 1239-50. PMID 22037639 DOI: 10.1097/Aln.0B013E318238C051 |
0.713 |
|
| 2011 |
Montana MC, Gereau RW. Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation. Current Pharmaceutical Biotechnology. 12: 1681-8. PMID 21466446 DOI: 10.2174/138920111798357438 |
0.609 |
|
| 2011 |
Zammataro M, Chiechio S, Montana MC, Traficante A, Copani A, Nicoletti F, Gereau RW. mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2/mGlu3 receptor agonists. Molecular Pain. 7: 6. PMID 21235748 DOI: 10.1186/1744-8069-7-6 |
0.715 |
|
| 2010 |
Kolber BJ, Montana MC, Carrasquillo Y, Xu J, Heinemann SF, Muglia LJ, Gereau RW. Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 8203-13. PMID 20554871 DOI: 10.1523/Jneurosci.1216-10.2010 |
0.681 |
|
| 2009 |
Montana MC, Cavallone LF, Stubbert KK, Stefanescu AD, Kharasch ED, Gereau RW. The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine. The Journal of Pharmacology and Experimental Therapeutics. 330: 834-43. PMID 19515968 DOI: 10.1124/Jpet.109.154138 |
0.595 |
|
| 2008 |
Cruz-Orengo L, Dhaka A, Heuermann RJ, Young TJ, Montana MC, Cavanaugh EJ, Kim D, Story GM. Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. Molecular Pain. 4: 30. PMID 18671867 DOI: 10.1186/1744-8069-4-30 |
0.304 |
|
| Show low-probability matches. |